Use of recombinant ganoderma lucidum immunomodulatory protein (rLZ-8) in preparation of medicine for treating melanoma

• 收藏
• 分享

专利权人:

Fei Sun;Xitian Zhang

发明人:

Zhang, Xitian,Sun, Fei,Liang, Chongyang

申请号：

AU2014308357

公开号：

AU2014308357A1

申请日:

2014.06.13

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

Disclosed in the present invention is the use of a recombinant Ganoderma lucidum immunomodulatory protein (rLZ-8) in the preparation of a medicine for resisting melanomas. The present invention uses in situ tumour and metastatic tumour experimental animal models to study the anti-tumour effect of rLZ-8, which have indicated that rLZ-8 can significantly inhibit melanoma in situ tumour growth and metastasis lesion formation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/